tadalafil has been researched along with Ischemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, M; Kashihara, N; Kidokoro, K; Maruyama, Y; Mitsui, Y; Nasu, Y; Sadahira, T; Sogawa, Y; Wada, K; Watanabe, M; Watanabe, T; Yoshinaga, K | 1 |
| McClain, SA; Singer, AJ; Towery, H | 1 |
| Arai, Y; Fujii, S; Goto, T; Hayashi, N; Ito, A; Izumi, H; Kawamorita, N; Kawasaki, Y; Koyama, J; Mitsuzuka, K; Sato, T; Shimada, S; Yamashita, S | 1 |
| Curnier, A; Tadros, A; Vaughan, EM; West, CC; Yeung, D | 1 |
| Elashoff, RM; Miceli, MC; Nelson, MD; Nelson, SF; Rader, F; Sweeney, HL; Tang, X; Tavyev, J; Victor, RG | 1 |
| Andersson, KE; Nomiya, M; Sawada, N; Zarifpour, M | 1 |
| Abassi, Z; Awad, H; Hussein, O; Khamaisi, M; Lahoud, Y; Matar, I; Nativ, O; Shalabi, A | 1 |
| Ayhan, S; Coskun, T; Kara, E; Kaya, Y; Sakarya, A; Var, A | 1 |
| Aytac, B; Gasanov, F; Vuruskan, H | 1 |
| Best, SL; Cadeddu, JA; Faddegon, S; Mir, SA; Olweny, EO; Park, SK; Tan, YK | 1 |
| Erkasap, N; Erkasap, S; Koken, T; Küçük, A; Ozkurt, M; Tosun, M; Yucel, M | 1 |
| Andersson, KE; Burmeister, DM; Campeau, L; Keys, T; Nomiya, M; Peyton, C; Sawada, N; Yamaguchi, O; Zarifpour, M | 1 |
| Anene, F; Barresi, R; Byrne, BJ; Elashoff, RM; Gurudevan, SV; Martin, EA; Scott, BL; Thomas, GD; Tsimerinov, EI; Victor, RG; Walker, AE | 1 |
| Asai, A; Kaneki, M; Martyn, JA; Ouchi, Y; Sahani, N; Yasuhara, SE | 1 |
3 trial(s) available for tadalafil and Ischemia
| Article | Year |
|---|---|
PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.
Topics: Adolescent; Carbolines; Child; Exercise; Forearm; Humans; Ischemia; Male; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Spectroscopy, Near-Infrared; Sulfones; Sympathetic Nervous System; Tadalafil; Ultrasonography; Vasoconstriction | 2014 |
Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma; Creatinine; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Ischemia; Kidney Neoplasms; Lipocalin-2; Lipocalins; Male; Membrane Glycoproteins; Middle Aged; Nephrectomy; Nephrons; Phosphodiesterase 5 Inhibitors; Prospective Studies; Proto-Oncogene Proteins; Receptors, Virus; Tadalafil | 2015 |
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
Topics: Adolescent; Adult; Animals; Biopsy; Carbolines; Child; Child, Preschool; Humans; Immunohistochemistry; Ischemia; Male; Mice; Middle Aged; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Phosphodiesterase 5 Inhibitors; Sympatholytics; Tadalafil; Young Adult | 2012 |
11 other study(ies) available for tadalafil and Ischemia
| Article | Year |
|---|---|
Evaluation of Neutrophil Dynamics Change by Protective Effect of Tadalafil After Renal Ischemia/Reperfusion Using In Vivo Real-time Imaging.
Topics: Acute Kidney Injury; Animals; Ischemia; Kidney; Mice; Neutrophils; Reperfusion; Reperfusion Injury; Tadalafil | 2022 |
Effect of tadalafil on reduction of necrosis in the ischemic zone in a rat comb burn model.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Burns; Disease Models, Animal; Disease Progression; Free Radical Scavengers; Ischemia; Naproxen; Necrosis; Random Allocation; Rats; Rats, Sprague-Dawley; Skin; Tadalafil; Vasodilator Agents | 2018 |
Phosphodiesterase type 5 inhibitor attenuates chronic ischemia-induced prostatic hyperplasia in a rat model.
Topics: Animals; Disease Models, Animal; Ischemia; Male; Phosphodiesterase 5 Inhibitors; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Tadalafil | 2019 |
Stiff fingers as an unwanted side effect of intravascular tadalafil gel abuse.
Topics: Adult; Amputation, Traumatic; Anticoagulants; Carbolines; Fingers; Gels; Heparin, Low-Molecular-Weight; Humans; Iloprost; Injections, Intra-Arterial; Ischemia; Male; Phosphodiesterase 5 Inhibitors; Prescription Drug Misuse; Radial Artery; Tadalafil; Vasodilator Agents | 2014 |
Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia.
Topics: Animals; Carbolines; Ischemia; Male; Prostate; Rats; Rats, Sprague-Dawley; Tadalafil; Vasodilator Agents | 2015 |
The effect of tadalafil on anastomotic healing in ischemic small intestine in rats.
Topics: Anastomosis, Surgical; Animals; Carbolines; Intestine, Small; Ischemia; Male; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Tadalafil; Wound Healing | 2010 |
The effects of tadalafil on renal ischemia reperfusion injury: an experimental study.
Topics: Animals; Carbolines; Ischemia; Kidney; Male; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tadalafil; Vasodilator Agents | 2011 |
Tadalafil for prevention of renal dysfunction secondary to renal ischemia.
Topics: Animals; Carbolines; Creatinine; Female; Ischemia; Kidney; Kidney Diseases; Phosphodiesterase 5 Inhibitors; Random Allocation; Reperfusion Injury; Statistics, Nonparametric; Swine; Tadalafil | 2012 |
The effects of PDE5 inhibitory drugs on renal ischemia/reperfusion injury in rats.
Topics: Animals; Apoptosis; Carbolines; Gene Expression; Ischemia; Kidney; Male; Malondialdehyde; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxidase; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sildenafil Citrate; Sulfones; Tadalafil; Tumor Suppressor Protein p53 | 2012 |
Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia.
Topics: Animals; Carbolines; Chronic Disease; Disease Models, Animal; Ischemia; Male; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Tadalafil; Urinary Bladder | 2013 |
Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy.
Topics: Animals; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Hydrogen Peroxide; Ischemia; Mice; Mice, Transgenic; Muscle Contraction; Muscular Dystrophy, Animal; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil | 2007 |